Trials / Completed
CompletedNCT00272285
A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea
A Double-blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Chemotherapy-Induced Vomiting and Nausea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of ramosetron plus dexamethasone injection with granisetron plus dexamethasone injection for the prevention of chemotherapy-induced vomiting and nausea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramosetron | IV, concomitant administration with dexamethasone |
| DRUG | Granisetron | IV, concomitant administration with dexamethasone |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2007-12-01
- Completion
- 2008-03-01
- First posted
- 2006-01-05
- Last updated
- 2017-03-09
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00272285. Inclusion in this directory is not an endorsement.